Prognostic factors for survival and response after high‐dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients

Philippe Moreau, Véronique Leblond, Priscille Bourquelot, +12

British Journal of Haematology

Prognostic FactorsCell TherapySystemic Al AmyloidosisImmunologyTransplantation Medicine +14

Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group

Michel Attal, Didier Blaise, Gérald Marit, +7

Blood

Comparison of High-Dose Therapy and Autologous Stem-Cell Transplantation With Conventional Therapy for Hodgkin's Disease Induction Failure: A Case-Control Study

Marc André, M. Henry‐Amar, José-Luis Pico, +14

Journal of Clinical Oncology

Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease.

Marc André, M. Henry‐Amar, Didier Blaise, +11

PubMed

The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin’s disease

Christophe Fermé, Y Bastion, Éric Lepage, +7

Annals of Oncology

Refractory Hodgkin ’Lymphoid NeoplasiaMine RegimenMedicineIntensive Salvage Chemotherapy +6

Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients

Pauline Brice, Y Bastion, Marine Diviné, +6

Cancer

Phase II trial of fludarabine monophosphate in patients with mantle-cell lymphomas.

Didier Decaudin, J. Bosq, G. Tertian, +7

Journal of Clinical Oncology

The Use of a Sequential High Dose Recombinant Interleukin 2 Regimen After Autologous Bone Marrow Transplantation Does Not Improve the Disease Free Survival of Patients with Acute Leukemia Transplanted in First Complete Remission

Didier Blaise, Michel Attal, José Luis Pico, +13

Leukemia & lymphoma/Leukemia and lymphoma

Intensive chemotherapy with idarubicin, cytosine arabinoside, and granulocyte colony-stimulating factor (G-CSF) in patients with secondary and therapy-related acute myelogenous leukemia

Claude Gardin, Thierry de Revel, Philippe Rousselot, +4

Leukemia

Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderImmunology +10

Characteristics of circulating megakaryocyte progenitors (CFU‐MK) in patients with primary myelofibrosis

ZC Han, J Brière, G. Nedellec, +4

European Journal Of Haematology